Your Brain on Psilocybin; Probiotics and Parkinson's; Alzheimer's Signaling News and commentary from the world of neurology and neuroscience Jan 21, 2020
Despite New Generic, MS Drug Costs Nearly Triple in 7 Years Generic glatiramer acetate "had a minimal effect on prices overall" Jan 15, 2020
Serum NfL Levels May Indicate MS Prodromal Phase Study shows elevated neurofilament light levels 6 years before MS onset Sep 16, 2019
Ofatumumab Cuts MS Relapse Rates, New Brain Lesions Anti-CD20 monoclonal antibody poised to take on ocrelizumab Sep 16, 2019
Ponesimod Bests Aubagio in Head-to-Head MS Trial Investigational drug reduces annual relapse rate, shows effects on fatigue Sep 12, 2019
IL-6 Inhibitor Cuts NMO Relapse Rates Satralizumab reduces attacks in neuromyelitis optica spectrum disorder Sep 11, 2019
Chronic, Active Lesions Tied to More Aggressive MS Smoldering inflammation seen even in patients treated with effective disease-modifying therapies Aug 12, 2019
Early MS Scans Predict Long-Term Outcomes MRI lesions seen 15 years prior linked to secondary progression and disability Jul 26, 2019
2019: 'The Year of NMO' Three different drugs report lower relapse rates in neuromyelitis optica spectrum disorder May 10, 2019
Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
Sugary Drinks May Up Disability in MS But overall diet quality not associated with disability status Mar 05, 2019
Alemtuzumab Benefits Persist in Multiple Sclerosis Many patients did not need additional treatment after first two courses of the drug Mar 03, 2019
Early Serum NfL Tied to Long-Term MS Brain Changes Early axonal damage may identify multiple sclerosis patients at risk for more severe disease Mar 01, 2019
Study Raises Questions on Nuedexta Prescribing Real-world data show PBA drug given mainly to dementia and Parkinson's disease patients Jan 07, 2019
Machine Learning Allows for Low-Dose Gadolinium Contrast Minimal loss of resolution with 10% Gd dose Nov 30, 2018
Elephants and Alzheimer's; Omega-3 and Epilepsy; Eye Disease and Dementia News and commentary from the world of neurology and neuroscience Aug 14, 2018
Calif. Medical Board Acts on Doc With Risky MS 'Cure' Physician featured in States of Disgrace series Jul 31, 2018
Some Multiple Sclerosis Agents May be Safe During Pregnancy Stopping treatment may put MS patients at unnecessary risk Jun 05, 2018
Still No Clarity on Role of Vitamin D in MS Relapse But findings do help estimate needed sample size for a future prospective study Jun 04, 2018
MRI Improvements in MS with Switch from IFN to Ocrelizumab Rapid and robust reduction in activity Jun 04, 2018
When Is the Ideal Time for Some MS Patients to Start DMT? Unclear benefits with disease-modifying therapies in older patients, asymptomatic patients Jun 03, 2018
Twice-a-Week IFN Dose an Option in Breakthrough MS Nearly two decades of data showed good outcomes Jun 02, 2018
Biologic for MS Linked to Reduced Vaccine Response Ocrelizumab treatment associated with decreased humoral response Jun 01, 2018
AAN 2018: Rare Disease Breakthroughs and Novel Approaches Noteworthy presentations at American Academy of Neurology meeting Apr 20, 2018
Docs, Medical Boards Ignored FDA Warning Letters on CCSVI Fueled by YouTube, bogus MS 'cure' peddled by docs licensed in multiple states Mar 28, 2018
Coffee and Cannabis; Stephen Hawking’s ALS; New Stroke Risk Loci News and commentary from the world of neurology and neuroscience Mar 20, 2018
NeuroBreak: Hits, Not Concussions, Cause CTE; Smoking and PD; APOE4 News News and commentary from the world of neurology and neuroscience Jan 23, 2018
Zamboni Stands By CCSVI Theory of MS His own RCT turns up negative, but he vows to fight on as MS community moves on Dec 26, 2017
New Immunoglobulin May Tell of MS Disease Severity Preliminary study implicates IgA in MS disease activity for first time Nov 15, 2017
Protein May Be Marker of MS Disease Severity, Remyelination Early work suggests beneficial effect of IL4I1 in multiple sclerosis Nov 13, 2017
Anti-Inflammatory Drug May Offer Benefit in Progressive MS Ibudilast seems to diminish brain volume loss Oct 29, 2017
Strike Three for Laquinimod in Relapsing MS Switching endpoints for third phase III trial didn't help Oct 27, 2017
Getting a Handle on Benign MS Prevalence varies by definition; agreed that disease progression varies widely Oct 27, 2017
Vaccines Tied to Relapses in Neuromyelitis Optica Retrospective review finds protective factor in immunotherapy Oct 26, 2017
Revised McDonald Diagnostic Criteria Revealed Recommends using OCBs, both symptomatic and asymptomatic lesions to diagnose MS Oct 26, 2017
FDA Panel Backs New Warning for Gadolinium Contrast Agents Manufacturers could be required to conduct new studies Sep 11, 2017
Lymphoma Case Reported in MS Patient on Aubagio First case in medical literature, more found in global surveillance reports Jul 07, 2017
